|Drug Name:||Ionosol and Dextrose|
|Other Info:||A MAINTENANCE ELECTROLYTE
Plastic ContainerRx only|
Ionosol B and 5% Dextrose Injection is indicated for intravenous
administration to patients who require a maintenance source of fluid and electrolytes. Ionosol
B and 5% Dextrose Injection is used in patients requiring polyionic fluid
maintenance, for alkalosis due to vomiting, diabetic acidosis, fluid losses
due to burns or stress and postoperative dehydration.
-- A pathological condition that removes acid or adds base to the body fluids.
-- The forcible expulsion of the contents of the STOMACH through the MOUTH.
-- A life-threatening complication of diabetes mellitus, primarily of TYPE 1 DIABETES MELLITUS with severe INSULIN deficiency and extreme HYPERGLYCEMIA. It is characterized by excessive LIPOLYSIS, oxidation of FATTY ACIDS, production of KETONE BODIES, a sweet smell to the breath (KETOSIS;) DEHYDRATION; and depressed consciousness leading to COMA.
-- The condition that results from excessive loss of water from a living organism.
Solutions containing potassium are contraindicated in diseases
where high potassium levels may be encountered.
-- A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.
Solutions which contain potassium ions should be used with
great care, if at all, in patients with hyperkalemia, severe renal failure
and in conditions in which potassium retention is present. Solutions
containing sodium ions should be used with great care, if at all, in patients
with congestive heart failure, severe renal insufficiency and in clinical
states in which there exists edema with sodium retention. In
patients with diminished renal function, administration of solutions containing
sodium or potassium ions may result in sodium or potassium retention. Solutions
containing lactate ions should be used with great care, if at all, in patients
with metabolic or respiratory alkalosis.
The administration of lactate ions
should be done with great care in those conditions in which there is an increased
level or an impaired utilization of lactate ions, such as severe hepatic insufficiency. The
intravenous administration of Ionosol B and 5% Dextrose Injection can cause
fluid and/or solute overloading resulting in dilution of serum electrolyte
concentrations, overhydration, congested states or pulmonary edema. The
risk of dilutional states is inversely proportional to the electrolyte concentrations
of administered parenteral solutions.
The risk of solute overload causing
congested states with peripheral and pulmonary edema is directly proportional
to the electrolyte concentrations of such solutions.
This web-site is for informational purposes only and is not intended as a substitute for advice from your doctor.
It should not to be used for self-diagnosis or treatment.